4.6 Review

Kynurenines as a Novel Target for the Treatment of Malignancies

Journal

PHARMACEUTICALS
Volume 14, Issue 7, Pages -

Publisher

MDPI
DOI: 10.3390/ph14070606

Keywords

tryptophan; kynurenine pathway; kynurenine; cancer; immune escape; indoleamine 2; 3-dioxygenase; tryptophan 2; 3-dioxygenase; enzyme inhibitors; cancer treatment

Funding

  1. Medical University of Bialystok

Ask authors/readers for more resources

Malignancies pose a significant public health challenge, with tumors developing mechanisms to evade treatment responses. The accumulation of tryptophan metabolites in the kynurenine pathway enhances neoplastic progression by suppressing the immune system's response, highlighting the potential for targeting this pathway in anticancer therapy. Various preclinical and clinical studies have been conducted on inhibiting enzymes in this pathway, showing promising results.
Malignancies are unquestionably a significant public health problem. Their effective treatment is still a big challenge for modern medicine. Tumors have developed a wide range of mechanisms to evade an immune and therapeutic response. As a result, there is an unmet clinical need for research on solutions aimed at overcoming this problem. An accumulation of tryptophan metabolites belonging to the kynurenine pathway can enhance neoplastic progression because it causes the suppression of immune system response against cancer cells. They are also involved in the development of the mechanisms responsible for the resistance to antitumor therapy. Kynurenine belongs to the most potent immunosuppressive metabolites of this pathway and has a significant impact on the development of malignancies. This fact prompted researchers to assess whether targeting the enzymes responsible for its synthesis could be an effective therapeutic strategy for various cancers. To date, numerous studies, both preclinical and clinical, have been conducted on this topic, especially regarding the inhibition of indoleamine 2,3-dioxygenase activity and their results can be considered noteworthy. This review gathers and systematizes the knowledge about the role of the kynurenine pathway in neoplastic progression and the findings regarding the usefulness of modulating its activity in anticancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available